We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSLV icon
6926
Sprott Physical Silver Trust
PSLV
$13.2B
$89.2K ﹤0.01%
9,245
+1,714
+23% +$18.1K
ZTR
6927
Virtus Total Return Fund
ZTR
$339M
$89.1K ﹤0.01%
15,212
-153
-1% -$920
ZNB
6928
Zeta Network Group
ZNB
$2.4M
$89K ﹤0.01%
+2
New +$540K
LICY
6929
DELISTED
Li-Cycle Holdings Corp.
LICY
$89K ﹤0.01%
49,698
+47,360
+2,026% +$102K
GFAI icon
6930
Guardforce AI
GFAI
$11M
$88.9K ﹤0.01%
+62,190
New +$75.1K
EPRX
6931
Eupraxia Pharmaceuticals
EPRX
$442M
$88.8K ﹤0.01%
28,000
-5,000
-15% -$14.8K
RVSB icon
6932
Riverview Bancorp
RVSB
$108M
$88.7K ﹤0.01%
15,452
+3,211
+26% +$16.5K
OFLX icon
6933
Omega Flex
OFLX
$312M
$88.6K ﹤0.01%
2,112
-355
-14% -$17.3K
OFS icon
6934
OFS Capital
OFS
$51.9M
$88.6K ﹤0.01%
10,975
-1,043
-9% -$8.55K
CGHM
6935
Capital Group Municipal High-Income ETF
CGHM
$3.25B
$88.3K ﹤0.01%
3,494
+3,210
+1,130% +$82.2K
LTRN icon
6936
Lantern Pharma
LTRN
$36.5M
$88.3K ﹤0.01%
27,684
+813
+3% +$2.78K
BILZ icon
6937
PIMCO Ultra Short Government Active ETF
BILZ
$1B
$88.2K ﹤0.01%
875
-180
-17% -$18.2K
DJIA icon
6938
Global X Dow 30 Covered Call ETF
DJIA
$188M
$88K ﹤0.01%
+3,925
New +$91.3K
FLCA icon
6939
Franklin FTSE Canada ETF
FLCA
$830M
$88K ﹤0.01%
2,403
+1,882
+361% +$71.3K
FMQQ icon
6940
FMQQ The Next Frontier Internet & Ecommerce ETF
FMQQ
$21.1M
$87.9K ﹤0.01%
6,998
+2,929
+72% +$39.2K
PFIX icon
6941
Simplify Interest Rate Hedge ETF
PFIX
$176M
$87.7K ﹤0.01%
+1,676
New +$80.1K
NBP
6942
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$87.6K ﹤0.01%
+103,054
New +$115K
LYRA
6943
DELISTED
LYRA THERAPEUTICS INC
LYRA
$87.5K ﹤0.01%
8,499
+8,001
+1,607% +$88K
DERM icon
6944
Journey Medical
DERM
$177M
$87.4K ﹤0.01%
+22,363
New +$122K
LOT
6945
Lotus Technology
LOT
$615M
$87.4K ﹤0.01%
+24,213
New +$103K
BHM icon
6946
Bluerock Homes Trust
BHM
$34.9M
$87.1K ﹤0.01%
6,565
+6,467
+6,599% +$94.2K
PTON icon
6947
PUT
Peloton Interactive
PTON
$2.46B
$87K ﹤0.01%
+10,000
New +$77.9K
RSF
6948
RiverNorth Capital and Income Fund
RSF
$58.9M
$86K ﹤0.01%
5,616
+3,197
+132% +$48.7K
FEAM icon
6949
5E Advanced Materials
FEAM
$62.3M
$86K ﹤0.01%
5,840
+5,834
+97,233% +$69.9K
PRLD icon
6950
Prelude Therapeutics
PRLD
$390M
$85.9K ﹤0.01%
67,390
+60,374
+861% +$80.1K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.